
Psychiatric News August 6, 2004
Volume 39 Number 15
© 2004 American Psychiatric Association
p. 36
PTSD Evaluations in Women Require `Delicate Balance'
Eve Bender
The first step in successful PTSD treatment is screening and diagnosis.
Taking a trauma history during the initial visit may help elicit traumatic
experiences that wouldn't be volunteered otherwise.
Not everyone who is subjected to trauma later develops posttraumatic stress
disorder (PTSD), but the very fact of being born female puts a person at
greater risk, according to a psychiatrist who specializes in women's mental
health issues.
The lifetime prevalence of PTSD for womenabout 10.4 percentis
more than twice that for men.
Psychiatrists should also be aware that women with PTSD may have unique
treatment needs, said Marian Butterfield, M.D., M.P.H., who spoke at APA's
annual meeting in New York in May as part of a symposium on women's mental
health issues sponsored by the Association of Women Psychiatrists.
Butterfield is an associate professor of psychiatry at Duke University and
director of women's mental health at the Durham Veterans Affairs Medical
Center.
Seldom do women patients who have sustained sexual trauma volunteer that
information when they begin seeing a psychiatrist. The effects of sexual
trauma may surface as depression, panic attacks, insomnia, suicidality,
somatic complaints, or addiction, she said.
Butterfield urged psychiatrists to conduct a trauma history on patients
during the initial visit, but to avoid the elicitation of "excruciating
detail," which can be upsetting for patients. "It's a delicate
balance on the first interviewavoiding voyeurism and keeping boundaries
intact," she noted.
When determining whether a patient has experienced trauma, it is sometimes
helpful for psychiatrists to make "normalizing" statements to let
patients know that experiencing trauma is not uncommon before asking them if
they have ever experienced trauma as a child or adult.
If the patient indicates that she has experienced sexual trauma, for
example, the psychiatrist should ask about the relationship of the patient to
the perpetrator, when the trauma occurred, the duration of the trauma, and the
patient's perception of the effect of the trauma on her life, Butterfield
said.
Empathizing with the patient can go a long way in helping her to feel
supported, Butterfield emphasized. Many of her patients have relayed stories
about "hostile treatment responses" from previous clinicians once
they bring up the issue of trauma, she noted, such as not being believed.
"When I ask them how they wish people would have responded,"
Butterfield said, "often the [desirable response] is as simple as
saying, `I'm sorry that happened to you.'"
While assessing patients for PTSD, it is also critical to assess them for
cormorbid disorders such as depression, anxiety disorders, and drug and
alcohol abuse or dependence, she said. "Comorbid psychotic symptoms may
be underdiagnosed in patients with PTSD" by clinicians, she said, and
can include auditory and visual hallucinations in addition to paranoid
delusions.
It is also necessary to screen for suicidality, since "PTSD patients
are six times more likely to attempt suicide than the general
population," she said.
Although further research is needed to understand gender differences in the
neurobiology of PTSD, Butterfield noted that the
hypothalamic-pituitary-adrenal axis of women's brains may be more reactive in
PTSD than is the case for men.
Butterfield pointed out that some women with PTSD have been found to
release more adrenocorticotropic hormone and cortisol. "There is some
question about whether this response is blunted in men," she noted.
It is also thought that fluctuations of estrogen and progesterone may
impact on hormonal modulation in neurotransmitter systems, Butterfield
added.
Both medications and psychotherapy are used to treat the symptoms of PTSD.
The goal of pharmacotherapy is to reduce symptoms of re-experiencing the
trauma, avoidance, numbing, and hyperarousal.
"We want to treat associated comorbidities and improve the quality of
life and resilience to stress by reducing the disability, stress, and
vulnerability, and also to facilitate nonpharmacologic therapies,"
Butterfield pointed out.
Selective serotonin reuptake inhibitors (SSRIs) are the first line of
treatment for patients with PTSD because they are especially "well
tolerated and safe," she said, and tricyclic antidepressants have also
been shown to be efficacious.
In instances in which SSRIs don't work for patients with PTSD, Butterfield
suggested targeting specific symptoms with different medications. For
instance, anti-adrenergic agents may work for hyperarousal symptoms, she said,
and for paranoia, an atypical antipsychotic is recommended. Anticonvulsant
medications may be helpful in reducing labile mood or impulsive behavior.
Although there has not been sufficient research on the efficacy of
psychodynamic psychotherapy on PTSD, Butterfield noted, its objective is to
explore the personal meaning of traumatic events, to "counter the
demoralization that is so inherent in traumatic stress," and to maintain
a focus on the trauma.
Two types of cognitive-behavioral therapy have been studied and used in
patients with PTSD. One uses systematic exposure to help patients confront
feared situations, objects, or images, and the other employs
anxiety-management exercises such as breathing, relaxation training, and
cognitive restructuring to help patients reduce symptoms of anxiety associated
with PTSD.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2004
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|